Professor Philip Britz-McKibbin

McMaster University, Department of Chemistry & Chemical Biology

Developing a New Paradigm for Metabolomic Screening

As most metabolites in our bodies originate from exposures such as diet and prescribed drugs, routine drug monitoring is critical to ensuring patient safety and their response to treatment. Professor Philip Britz-McKibbin and his team have developed a new technique that overcomes the throughput limitations of traditional drug screening methods while maintaining accuracy and data quality.

LIKE 0


Professor Philip Britz-McKibbin
Drug Discovery Mass Spectrometry

Professor Philip Britz-McKibbin

Biography

Prof. Philip Britz-McKibbin, PhD, works on a number of collaborative research projects that have strong translational potential in clinical medicine and public health. More
Follow Philip

Professor Philip Britz-McKibbin

McMaster University, Department of Chemistry & Chemical Biology

Philip Britz-McKibbin received his PhD in analytical chemistry (2000) from the University of British Columbia, followed by a Japan Society for Promotion of Science post-doctoral research fellowship in the renowned group of Shigeru Terabe at Himeji Institute of Technology (2001-2003). He started his independent career in 2003 at McMaster University, and is currently a Cystic Fibrosis Canada Researcher and Professor at the Department of Chemistry and Chemical Biology, and an affiliate member of the Department of Pathology and Molecular Medicine. He is also an affiliate member of the Metabolomics Innovation Centre (TMIC) – Canada’s national laboratory for metabolomics research and innovative analytical services. His work involves innovative collaborative research projects that have strong translational potential in clinical medicine and public health.